The Cigna Group has leveraged its dual-segment platform—Evernorth Health Services alongside Cigna Healthcare—to achieve robust revenue growth of 11.2% in FY2025, despite slight operating income compression. Specialty pharmacy volumes coupled with value-based payment models are central to this growth dynamic, while margin pressures persist amid competitive pricing and rebate-sharing. Digital innovation, extensive provider networks, and AI health solutions form the backbone of future expansion potential. Regulatory scrutiny and intense competition remain material risks. Capital allocation reflects a balance of steady dividends, sizable yet moderated buybacks, and reinvestment evidenced by a near doubling in capex.